Journal of the Neurological Sciences
Volume 208, Issue 1 , Pages 39-42 , 15 April 2003

HIV-associated Guillain–Barré syndrome

  • Thomas H Brannagan III

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-212-888-8516; fax: +1-212-888-9206.
    • Department of Neurology, Weill Medical College of Cornell University, Peripheral Neuropathy Center, 635 Madison Avenue, Suite 400 New York, NY 10022, USA
    • ,
  • Yili Zhou

      Affiliations

    • University of Miami, Miami, FL, USA

Received 12 August 2002 ,Accepted 23 October 2002.

References 

  1. Brannagan TH, McAlarney T, Latov N. Peripheral neuropathy in HIV-1 infection. In:  Latov N,  Wokke JHJ,  Kelly JJ editor. Immunological and infectious diseases of the peripheral nerves. Cambridge: Cambridge Univ. Press; 1998;p. 285–307
  2. Cornblath DR, McArthur JC. Peripheral neuropathies in human immunodeficiency virus type 1 infection. In:  Asbury AK,  Thomas PK editor. Peripheral Nerve Disorders. vol. 2:Oxford: Butterworth; 1995;p. 223–237
  3. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann. Intern. Med. 1994;121:769–785
  4. Cornblath DR, McArthur JC, Kennedy PGE, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann. Neurol. 1987;21:32040
  5. Asbury AK. Diagnostic consideration in Guillain–Barré syndrome. Ann. Neurol. 1981;9(suppl.):1–5
  6. Centers for Disease Control and Prevention . 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. 1992;41(RR-17):1–19
  7. Mishra BB, Sommers W, Koski CL, Greenstein JI. Acute inflammatory demyelinating polyneuropathy in the acquired immune deficiency syndrome. Ann. Neurol. 1985;18:131–132
  8. Piette AM, Tusseau F, Vignon D. Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III. Lancet. 1986;(1):852
  9. Vendrell J, Heredia C, Pujol M, Vidal J, Blesa R, Graus F. Guillian–Barré syndrome associated with seroconversion for anti-HTLV-III. Neurology. 1987;37:544
  10. Fuller GN, Jacobs JM, Guiloff RJ. Nature and incidence of peripheral nerve syndromes in HIV infection. J. Neurol. Neurosurg. Psychiatry. 1993;56:372–381
  11. Thornton CT, Latif AS, Emmanuel JC. Guillain–Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology. 1991;41:812–815
  12. Parry O, Mielke J, Latif AS, Ray S, Levy LF, Siziya S. Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurol. Scand. 1997;96:218–222
  13. Qureshi AI, Cook AA, Mishu H, Krendel DA. Guillain–Barré syndrome in immunocompromised patients: a report of three patients and review of the literature. Muscle Nerve. 1997;20:1002–1007
  14. Morgello S, Simpson DM. Multifocal cytomegalovirus demyelinative polyneuropathy associated with AIDS. Muscle Nerve. 1995;17:176–182
  15. Cornblath DR, McArthur JC, Parry GJG, Griffin JW. Peripheral neuropathies in human immunodeficiency virus infection. In:  Dyck PJ,  Thomas PK,  Griffin JW,  Low PA,  Poduslo JF editor. Peripheral neuropathy. 3rd ed.. Philadelphia: Saunders; 1993;p. 1343–1353
  16. Arnason BGW, Soliven B. Acute inflammatory demyelinating polyradiculoneuropathy. In:  Dyck PJ,  Thomas PK,  Griffin JW,  Low PA,  Poduslo JF editor. Peripheral neuropathy. 3rd ed.. Philadelphia: Saunders; 1993;p. 1437–1497
  17. Castro LH, Ropper AH. Human immune globulin infusion in Guillain–Barré syndrome: worsening during and after treatment. Neurology. 1993;43:1034–1036
  18. Irani DN, Cornblath DR, Chaudhry V, Borel C, Hanley DF. Relapse in Guillain–Barré syndrome after treatment with human immune globulin. Neurology. 1993;43:872–875
  19. Plasma Exchange/Sandoglobulin Guillain–Barré Syndrome Trial Group . Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain–Barré syndrome. Lancet. 1997;349:225–230

☆ Presented in part in abstract form at the 47th annual meeting of the American Association of Electrodiagnostic Medicine, Philadelphia, PA, September 13–16, 2000.

PII: S0022-510X(02)00418-5

doi: 10.1016/S0022-510X(02)00418-5

Journal of the Neurological Sciences
Volume 208, Issue 1 , Pages 39-42 , 15 April 2003

Article Tools

* Image Usage & Resolution